Desvenlafaxine
NDC Package 46708-252-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Desvenlafaxine is a . Marketed by Alembic Pharmaceuticals Limited, this product is identified by NDC 46708-252 and is authorized under FDA application ANDA204003.

Identification & Billing

NDC Package Code
46708-252-90
Package Description
90 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code
46708-252
11-Digit Billing Format
46708025290

Clinical Specifications

Proprietary Name
Desvenlafaxine
Dosage Form
-

Regulatory & Marketing

Labeler Name
Alembic Pharmaceuticals Limited
FDA Application #
ANDA204003
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-01-2017
End Marketing Date
10-25-2018
Listing Expiration
10-25-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (46708-252). Click a package code to view its specific billing and regulatory data.

46708-252-08
80 TABLET, EXTENDED RELEASE in 1 CARTON
46708-252-10
100 TABLET, EXTENDED RELEASE in 1 CARTON
46708-252-17
14 TABLET, EXTENDED RELEASE in 1 BOTTLE
46708-252-30
30 TABLET, EXTENDED RELEASE in 1 BOTTLE
46708-252-31
100 TABLET, EXTENDED RELEASE in 1 BOTTLE
46708-252-91
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 46708-252-90 identifies a specific commercial package of 90 tablet, extended release in 1 bottle of Desvenlafaxine, labeled by Alembic Pharmaceuticals Limited. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Alembic Pharmaceuticals Limited on March 01, 2017. The current certification is valid through October 25, 2018.

How is this Alembic Pharmaceuticals Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 46708025290. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
46708-252-90
11-Digit CMS (5-4-2)
46708-0252-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.